En DE FR ES PL
Memoplant - instructions for use, analogs, reviews and release forms (tablets 40 mg, 80 mg and 120 mg) of the drug to treat impairment of attention, memory, circulatory disorders of the brain in adults, children and pregnancy. Composition

Memoplant - instructions for use, analogs, reviews and release forms (tablets 40 mg, 80 mg and 120 mg) of the drug to treat impairment of attention, memory, circulatory disorders of the brain in adults, children and pregnancy. Composition

In this article, you can read the instructions for using the drug Memoplant. Comments of visitors of the site - consumers of this medication, as well as opinions of doctors of specialists on the use of the Memo in their practice are presented. A big request is to actively add their feedback on the drug: the medicine helped or did not help get rid of the disease, which were observed complications and side effects, possibly not declared by the manufacturer in the annotation. Analogues of the Memo in the presence of existing structural analogues.Use to treat impairment of attention, memory, circulatory disorders of the brain in adults, children, as well as during pregnancy and lactation. Composition of the preparation.

 

Memoplant - a preparation of vegetable origin. Increases the body's resistance to hypoxia, especially brain tissue. It inhibits the development of traumatic or toxic edema of the brain. Improves cerebral and peripheral blood circulation, improves blood rheology.

 

Has a dose-dependent regulatory effect on the vascular system, dilates the small arteries, increases the tone of the veins. Prevents formation of free radicals and peroxide oxidation of cell membrane lipids. Normalizes the release, re-uptake and catabolism of neurotransmitters (norepinephrine, dopamine, acetylcholine) and their ability to combine with receptors. It improves the metabolism in organs and tissues, promotes accumulation of macroerges in cells, increases utilization of oxygen and glucose, normalization of mediator processes in the central nervous system.

 

Composition

 

Dry standardized extract of leaves of Ginkgo Biloba + auxiliary substances.

 

Pharmacokinetics

 

The effect of the drug Memoplant is the combined action of the extract components of the leaves of the ginkgo biloba, therefore it is not possible to carry out kinetic studies.

 

Indications

  • disorders of the brain, incl. age associated with impaired cerebral circulation and accompanied by the following symptoms: memory impairment, decreased ability to concentrate attention and intellectual abilities, dizziness, tinnitus, headache;
  • violations of peripheral circulation (obliterating diseases of arteries of the lower extremities with such characteristic symptoms as intermittent claudication, numbness and cold snap, Raynaud's disease);
  • disorders of the inner ear, manifested by dizziness, unstable gait and noise in the ears.

 

Forms of release

 

Tablets coated with 40 mg, 80 mg and 120 mg.

 

Instructions for use and dosing regimen

 

Tablets 40 mg

 

For symptomatic treatment of disorders of cerebral circulation appoint 1-2 tablets (40-80 mg of dry standardized extract of leaves of ginkgo bilobate) 3 times a day. The course of treatment is not less than 8 weeks.

 

In peripheral circulation disorders, 1 tablet (40 mg of dry, standardized extract of ginkgo bilobate leaves) is prescribed 3 times a day or 2 tablets (80 mg of dry, standardized extract of ginkgo bilobate leaves) 2 times a day. The course of treatment - at least 6 weeks.

 

In case of vascular or involutional pathology of the inner ear, 1 tablet (40 mg of dry standardized extract of ginkgo bilobate leaf) is prescribed 3 times a day or 2 tablets (80 mg of dry, standardized extract of ginkgo bilobate leaves) 2 times a day. The course of treatment is 6-8 weeks.

 

Tablets 80 mg

 

For symptomatic treatment of disorders of cerebral circulation, one tablet (80 mg of dry, standardized extract of ginkgo bilobate leaves) is prescribed 2-3 times a day. The course of treatment is not less than 8 weeks.

 

In case of violations of peripheral circulation, 1 tablet (80 mg of dry, standardized extract of ginkgo bilobate leaves) is prescribed 2 times a day. The course of treatment - at least 6 weeks.

 

In vascular or involutional pathology of the inner ear, 1 tablet (80 mg of dry, standardized extract of ginkgo bilobate leaves) is prescribed 2 times a day. The course of treatment is 6-8 weeks.

 

Tablets 120 mg

 

Assign 1 tablet (120 mg of dry, standardized extract of ginkgo leaves bilobate) 1-2 times a day. The duration of treatment depends on the severity of the disease and should last at least 8 weeks.

 

If there are no results, after 3 months of treatment, the further treatment should be evaluated.

 

Tablets should be taken without chewing, washed down with a small amount of water. The drug is taken regardless of food intake.

 

In case of skipping of the drug or if an insufficient amount was taken, the subsequent administration should be carried out as indicated in the dosing regimen, without any changes.

 

Side effect

  • redness, skin rash, swelling of the skin;
  • itching;
  • headache;
  • dizziness;
  • hearing impairment;
  • decreased blood clotting;
  • bleeding observed in patients who simultaneously took funds that reduce blood clotting (the connection of these bleeding with the use of ginkgo biloba preparations is not confirmed);
  • gastrointestinal disorders (nausea, vomiting, diarrhea).

 

In case of side effects, the drug should be discontinued and the patient should consult a doctor.

 

Contraindications

  • decreased blood clotting;
  • erosive gastritis;
  • peptic ulcer of the stomach and duodenum in the phase of exacerbation;
  • acute disorders of cerebral circulation;
  • acute myocardial infarction;
  • children under 12 years (for tablets 40 mg) (due to insufficient data);
  • children under 18 (for tablets 80 mg and 120 mg) (due to insufficient data);
  • hypersensitivity to the components of the drug.

 

Application in pregnancy and lactation

 

In connection with the lack of sufficient clinical data, it is not recommended to use the drug Memoplant during pregnancy and lactation.

 

Use in children

 

Contraindicated in children under 12 years (for tablets 40 mg) due to insufficient data; in children under 18 years (for tablets 80 mg and 120 mg) due to insufficient data.

 

special instructions

 

The patient should be informed that with frequent feelings of dizziness and tinnitus, consult a doctor. In case of sudden deterioration or loss of hearing, you should immediately consult a doctor.

 

The composition of the tablets includes lactose, so the drug is not recommended for patients with congenital galactosemia,syndrome of malabsorption of glucose or galactose, or with congenital lactase deficiency.

 

Drug Interactions

 

It is not recommended the appointment of the drug Memoplant to patients who constantly take acetylsalicylic acid, anticoagulants (direct and indirect action), as well as drugs that reduce blood clotting.

 

Analogues of the drug Memoplant

 

Structural analogs for the active substance:

  • Bilobil;
  • Bilobil intensive 120;
  • Bilobil forte;
  • Vitrum Memori;
  • Gingiium;
  • Ginkgo biloba;
  • Ginkyo;
  • Ginkoum;
  • Ginos;
  • Tanakan.

Similar medicines:

Other medicines:

Reviews (0):

Rules for publishing reviews and visitor questions